Ajanta Pharma reports 20% fall in Q2 consolidated net profit

04 Nov 2022 Evaluate

Ajanta Pharma has reported results for second quarter ended September 30, 2022.

The company has reported a fall of 15.07% in its net profit at Rs 167.18 crore for the quarter under review as compared to Rs 196.85 crore for the same quarter in the previous year. However, total income of the company increased by 4.51% at Rs 915.60 crore for Q2FY23 as compared Rs 876.12 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported fall of 20.08% in its net profit at Rs 156.60 crore for the quarter under review as compared to Rs 195.94 crore for the same quarter in the previous year. However, total income of the company increased by 7.01% at Rs 978.45 crore for Q2FY23 as compared Rs 914.34 crore for the corresponding quarter previous year.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×